JP2004535166A5 - - Google Patents

Info

Publication number

JP2004535166A5

JP2004535166A5 JP2002575305A JP2002575305A JP2004535166A5 JP 2004535166 A5 JP2004535166 A5 JP 2004535166A5 JP 2002575305 A JP2002575305 A JP 2002575305A JP 2002575305 A JP2002575305 A JP 2002575305A JP 2004535166 A5 JP2004535166 A5 JP 2004535166A5

Authority

JP

Japan

Prior art keywords

polypeptide

nucleotide sequence

cvsp14

seq

double

Prior art date

2002-03-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 claims 140
• 229920001184 polypeptide Polymers 0.000 claims 138
• 102000004196 processed proteins & peptides Human genes 0.000 claims 138
• 125000003729 nucleotide group Chemical group 0.000 claims 55
• 239000002773 nucleotide Substances 0.000 claims 52
• 238000000034 method Methods 0.000 claims 42
• 150000001875 compounds Chemical class 0.000 claims 31
• 108091005804 Peptidases Proteins 0.000 claims 23
• 239000004365 Protease Substances 0.000 claims 23
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 23
• 150000007523 nucleic acids Chemical class 0.000 claims 23
• 108020004707 nucleic acids Proteins 0.000 claims 21
• 102000039446 nucleic acids Human genes 0.000 claims 21
• 238000012360 testing method Methods 0.000 claims 18
• 210000004027 cell Anatomy 0.000 claims 17
• 125000003275 alpha amino acid group Chemical group 0.000 claims 15
• 235000001014 amino acid Nutrition 0.000 claims 15
• 239000000758 substrate Substances 0.000 claims 15
• 150000001413 amino acids Chemical class 0.000 claims 14
• 239000003795 chemical substances by application Substances 0.000 claims 14
• 239000013598 vector Substances 0.000 claims 12
• 230000000694 effects Effects 0.000 claims 8
• 230000002797 proteolythic effect Effects 0.000 claims 8
• 230000000295 complement effect Effects 0.000 claims 7
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 6
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 6
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
• 230000003197 catalytic effect Effects 0.000 claims 6
• 230000008685 targeting Effects 0.000 claims 6
• 238000011282 treatment Methods 0.000 claims 6
• 108020004705 Codon Proteins 0.000 claims 5
• 239000003112 inhibitor Substances 0.000 claims 5
• 210000004962 mammalian cell Anatomy 0.000 claims 5
• 239000007787 solid Substances 0.000 claims 5
• 210000001519 tissue Anatomy 0.000 claims 5
• 241000124008 Mammalia Species 0.000 claims 4
• 239000012472 biological sample Substances 0.000 claims 4
• 201000010099 disease Diseases 0.000 claims 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
• 239000012634 fragment Substances 0.000 claims 4
• 108020004999 messenger RNA Proteins 0.000 claims 4
• 230000001613 neoplastic effect Effects 0.000 claims 4
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 3
• 108091034117 Oligonucleotide Proteins 0.000 claims 3
• 230000000259 anti-tumor effect Effects 0.000 claims 3
• 238000001514 detection method Methods 0.000 claims 3
• 238000002955 isolation Methods 0.000 claims 3
• 230000003211 malignant effect Effects 0.000 claims 3
• 238000000746 purification Methods 0.000 claims 3
• 150000003384 small molecules Chemical class 0.000 claims 3
• 208000024891 symptom Diseases 0.000 claims 3
• 108010062466 Enzyme Precursors Proteins 0.000 claims 2
• 102000010911 Enzyme Precursors Human genes 0.000 claims 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 2
• 206010028980 Neoplasm Diseases 0.000 claims 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
• 230000001772 anti-angiogenic effect Effects 0.000 claims 2
• 230000000692 anti-sense effect Effects 0.000 claims 2
• 239000000074 antisense oligonucleotide Substances 0.000 claims 2
• 238000012230 antisense oligonucleotides Methods 0.000 claims 2
• 210000004369 blood Anatomy 0.000 claims 2
• 239000008280 blood Substances 0.000 claims 2
• 210000000481 breast Anatomy 0.000 claims 2
• 210000003679 cervix uteri Anatomy 0.000 claims 2
• 238000012258 culturing Methods 0.000 claims 2
• 239000012530 fluid Substances 0.000 claims 2
• 210000003000 inclusion body Anatomy 0.000 claims 2
• 230000002401 inhibitory effect Effects 0.000 claims 2
• 210000004072 lung Anatomy 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 229930014626 natural product Natural products 0.000 claims 2
• 210000001672 ovary Anatomy 0.000 claims 2
• 239000000816 peptidomimetic Substances 0.000 claims 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 2
• 210000002307 prostate Anatomy 0.000 claims 2
• 210000003296 saliva Anatomy 0.000 claims 2
• 210000004243 sweat Anatomy 0.000 claims 2
• 210000001179 synovial fluid Anatomy 0.000 claims 2
• 230000005751 tumor progression Effects 0.000 claims 2
• 210000002700 urine Anatomy 0.000 claims 2
• WPVINHLVHHPBMK-ULQDDVLXSA-N (2s)-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-[(2s)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide Chemical group C([C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)CCN1C(=O)[C@@H]1CCC(=O)N1 WPVINHLVHHPBMK-ULQDDVLXSA-N 0.000 claims 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 claims 1
• 206010003445 Ascites Diseases 0.000 claims 1
• 206010006187 Breast cancer Diseases 0.000 claims 1
• 208000026310 Breast neoplasm Diseases 0.000 claims 1
• 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims 1
• 241000588724 Escherichia coli Species 0.000 claims 1
• 241000238631 Hexapoda Species 0.000 claims 1
• 241001465754 Metazoa Species 0.000 claims 1
• 206010061309 Neoplasm progression Diseases 0.000 claims 1
• 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
• 241000235648 Pichia Species 0.000 claims 1
• 208000006994 Precancerous Conditions Diseases 0.000 claims 1
• 102100037942 Suppressor of tumorigenicity 14 protein Human genes 0.000 claims 1
• 101710098606 Suppressor of tumorigenicity 14 protein homolog Proteins 0.000 claims 1
• 230000004913 activation Effects 0.000 claims 1
• 239000012190 activator Substances 0.000 claims 1
• 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
• 210000004102 animal cell Anatomy 0.000 claims 1
• 239000002246 antineoplastic agent Substances 0.000 claims 1
• 230000001580 bacterial effect Effects 0.000 claims 1
• 238000001574 biopsy Methods 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 210000001124 body fluid Anatomy 0.000 claims 1
• 239000010839 body fluid Substances 0.000 claims 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
• 239000003593 chromogenic compound Substances 0.000 claims 1
• 238000003776 cleavage reaction Methods 0.000 claims 1
• 208000029742 colonic neoplasm Diseases 0.000 claims 1
• 210000000805 cytoplasm Anatomy 0.000 claims 1
• 239000000539 dimer Substances 0.000 claims 1
• 230000002255 enzymatic effect Effects 0.000 claims 1
• 210000003527 eukaryotic cell Anatomy 0.000 claims 1
• 239000013604 expression vector Substances 0.000 claims 1
• 210000003722 extracellular fluid Anatomy 0.000 claims 1
• 230000006801 homologous recombination Effects 0.000 claims 1
• 238000002744 homologous recombination Methods 0.000 claims 1
• 210000002429 large intestine Anatomy 0.000 claims 1
• 230000003902 lesion Effects 0.000 claims 1
• 208000020816 lung neoplasm Diseases 0.000 claims 1
• 208000037841 lung tumor Diseases 0.000 claims 1
• 238000012986 modification Methods 0.000 claims 1
• 230000004048 modification Effects 0.000 claims 1
• 238000012544 monitoring process Methods 0.000 claims 1
• 230000035772 mutation Effects 0.000 claims 1
• 230000007170 pathology Effects 0.000 claims 1
• 210000001236 prokaryotic cell Anatomy 0.000 claims 1
• 208000023958 prostate neoplasm Diseases 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 claims 1
• 239000000523 sample Substances 0.000 claims 1
• 230000007017 scission Effects 0.000 claims 1
• 230000028327 secretion Effects 0.000 claims 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
• 241000894007 species Species 0.000 claims 1
• 239000000126 substance Substances 0.000 claims 1
• 238000006467 substitution reaction Methods 0.000 claims 1
• 210000001138 tear Anatomy 0.000 claims 1
• 230000009261 transgenic effect Effects 0.000 claims 1
• 230000005748 tumor development Effects 0.000 claims 1
• 230000004614 tumor growth Effects 0.000 claims 1
• 208000024719 uterine cervix neoplasm Diseases 0.000 claims 1
• 210000005253 yeast cell Anatomy 0.000 claims 1